Why the study?
Hypertension is a modifiable risk factor for cardiovascular events, but the role of intensive blood pressure control in preventing kidney disease progression continues to be debated.
Does intensive blood pressure control improve kidney outcomes in patients with chronic kidney disease?
Population
Patients with chronic kidney disease (CKD)
Comparison
Intensive blood pressure control vs standard blood pressure control
Design
Review
Key result
Intensive blood pressure control (target 120-130 mmHg) confers cardiovascular benefits but yields mixed results for adverse kidney outcomes, reducing kidney replacement therapy risk in CKD stage 4-5.
Authors
Loading...
May support intensive targets to delay dialysis in advanced CKD; leaves open net kidney effects in milder disease.
Does intensive blood pressure control improve kidney outcomes in patients with chronic kidney disease?
While intensive BP control offers clear cardiovascular benefits in CKD patients, its impact on kidney disease progression remains mixed, with potential benefits in advanced CKD but also some signals of kidney risk.
Huang et al. (2025) conducted a review in Chronic kidney disease and hypertension. Intensive blood pressure control vs. Standard blood pressure control was evaluated on Kidney outcomes and cardiovascular events. Intensive blood pressure control (target 120-130 mmHg) confers cardiovascular benefits but yields mixed results for adverse kidney outcomes, reducing kidney replacement therapy risk in CKD stage 4-5.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: